Discussions reveal strong agreement with the benefits of minoxidil, exemplified by comments on its various formulations like foam and solution, and mentions of its mechanism as a vasodilator and anti-inflammatory agent. The tone and language focus on practical applications and potential effectiveness, indicating active interest and moderate engagement with the review's contents.
AgreementModerate agreement
Most discussions show support or accept the findings of the comprehensive review on minoxidil, indicated by mentions of positive effects and approval status.
InterestHigh interest
The posts demonstrate a high level of curiosity about formulations, dosages, and applications, reflecting genuine interest in the topic.
EngagementModerate engagement
Participants reference mechanisms of action, formulation details, and express opinions, suggesting moderate but meaningful engagement.
ImpactModerate impact
The discussions could influence opinions or behaviors regarding hair loss treatments, as users highlight the effectiveness and approval status of minoxidil.
Abstract in brief
Minoxidil is FDA-approved for treating androgenetic alopecia (AGA) in men and women, and it works through multiple mechanisms including vasodilation, anti-inflammatory effects, promoting hair growth pathways, and possibly acting as an antiandrogen.
Approximately 14% of topical minoxidil is absorbed through the skin, where it is metabolized into its active form, minoxidil sulfate, by follicular sulfotransferase, with response rates varying based on enzyme activity.
The treatment generally shows peak hair growth around the first year, with similar efficacy between different formulations (foam and solution), and lower doses may still be effective, especially for female pattern hair loss; sublingual delivery might also be a safe option.
Minoxidil: a comprehensive review: Topical minoxidil (5% foam, 5% solution, 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent,… https://t.co/9Vjt2HaYFj
This video reviews a clinical trial comparing 5% and 2% topical minoxidil for male androgenetic alopecia, showing that 5% leads to about 45% more hair regrowth and earlier response, despite increased skin irritation.
Minoxidil is FDA-approved for androgenetic alopecia and works through vasodilation, anti-inflammatory effects, and promoting hair growth pathways, potentially acting as an antiandrogen. About 14% is absorbed and…
Minoxidil: a comprehensive review: Topical minoxidil (5% foam, 5% solution, 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent,… https://t.co/9Vjt2HaYFj
JEADV Clinical Practice - 2022 - Dominguez Santas - The State of ...
News
https://doi.org/10.1080/09546634.2021.1945527. AGA and a framework to help the dermatologist navigate 5. Gupta AK, Venkataraman M, Talukder M, Bamimore MA ...